CTOs on the Move

Neuralstem

www.neuralstem.com

 
Neuralstem is a dual platform regenerative medicine company. The company`s technology enables the production of regionally specific, physiologically relevant neural stem cells for therapeutic use for the treatment of central nervous system (CNS) diseases and has enabled the discovery of a library of patented small molecule neurogenic compounds to treat psychological and cognitive disorders. Neuralstem`s small molecule drug discovery program screens human neural stem cell lines for compounds that may stimulate neurogenesis in the brain, possibly reversing pathologies associated with certain CNS conditions. The company`s lead compound, NSI-189, has completed FDA Phase Ia and Ib safety trials for the treatment of ...
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.neuralstem.com
  • 20271 Goldenrod Lane 2nd Floor
    Germantown, MD USA 20876
  • Phone: 301.366.4960

Executives

Name Title Contact Details

Similar Companies

Mountain States Health Alliance

Mountain States Health Alliance (MSHA), formed in 1998, is the largest health care system in Northeast Tennessee and Southwest Virginia.   Our approximately 9,000 team members, associated physicians and volunteers bring loving care to health care every day in each of our facilities.

The Heart and Family Health Institute of Port St. Lucie

The Heart and Family Health Institute of Port St. Lucie is a Port Saint Lucie, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Relmada

Relmada Therapeutics (OTCQB: RLMD) is a clinical-stage, publicly traded specialty pharmaceutical company developing novel versions of proven drug products together with new chemical entities that potentially address areas of high unmet medical need in the treatment of chronic pain. Relmada has a diversified portfolio of four lead products at various stages of development including d-Methadone (REL-1017) its N-methyl-D-aspartate (NMDA) receptor antagonist for neuropathic pain; topical mepivacaine (REL-1021), its orphan drug designated topical formulation of the local anesthetic mepivacaine; oral buprenorphine (REL-1028) its oral dosage form of the opioid analgesic buprenorphine; and LevoCap ER (REL-1015), its abuse resistant, sustained release dosage form of the opioid analgesic levorphanol. Relmada`s product development efforts are guided by the internationally recognized scientific expertise of our research team. Relmada`s approach is expected to reduce clinical development risks and costs while potentially delivering valuable products in areas of high unmet medical needs.

Transhealth

Transhealth is a Brentwood, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sav-Rx

Sav-Rx is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.